Oxford Biomedica PLC ORD 1P

(LSE, Stocks) 
p 14.96 <%= Resources.Global.txtDown %>
Updated 11:35:25
Change % -0.28% Stock price decreasing
Change -0.0425 Stock price decreasing
Volume 1,911,561
High P 15.02
Low P 14.89
Open P 15.02
ISIN GB0006648157
Prev close P 15.00
# of shares 3,284.31M
Market cap 49,125M GBX

Oxford Biomedica PLC ORD 1P
Market is open (until 16:30) - Delayed 15 min
Price development Latest 1 week 1 month 3 months 6 months 1 year
  14.96 -0.2% Stock price decreasing 24.4% Stock price increasing 24.9% Stock price increasing 75.8% Stock price increasing 206.5% Stock price increasing
Powered by TradingView

Company profile

Oxford BioMedica PLC is a player in the healthcare market in the United Kingdom. As a biopharmaceutical company, it focusses on the field of immunotherapy by managing a platform of technologies in designing gene based medicines. Its registered product LentiVector is a proprietary single dose gene therapy platform, through which it develops gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
22 May 2018 13:10:44
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180515.2 - EUROWEB2 - 2018-05-22 14:10:44 - 2018-05-22 13:10:44 - 1000 - Website: OKAY